Bipolar disorder with binge eating behavior: a genome-wide association study implicates PRR5-ARHGAP8

Abstract

Bipolar disorder (BD) is associated with binge eating behavior (BE), and both conditions are heritable. Previously, using data from the Genetic Association Information Network (GAIN) study of BD, we performed genome-wide association (GWA) analyses of BD with BE comorbidity. Here, utilizing data from the Mayo Clinic BD Biobank (969 BD cases, 777 controls), we performed a GWA analysis of a BD subtype defined by BE, and case-only analysis comparing BD subjects with and without BE. We then performed a meta-analysis of the Mayo and GAIN results. The meta-analysis provided genome-wide significant evidence of association between single nucleotide polymorphisms (SNPs) in PRR5-ARHGAP8 and BE in BD cases (rs726170 OR = 1.91, P = 3.05E-08). In the meta-analysis comparing cases with BD with comorbid BE vs. non-BD controls, a genome-wide significant association was observed at SNP rs111940429 in an intergenic region near PPP1R2P5 (p = 1.21E-08). PRR5-ARHGAP8 is a read-through transcript resulting in a fusion protein of PRR5 and ARHGAP8. PRR5 encodes a subunit of mTORC2, a serine/threonine kinase that participates in food intake regulation, while ARHGAP8 encodes a member of the RhoGAP family of proteins that mediate cross-talk between Rho GTPases and other signaling pathways. Without BE information in controls, it is not possible to determine whether the observed association reflects a risk factor for BE in general, risk for BE in individuals with BD, or risk of a subtype of BD with BE. The effect of PRR5-ARHGAP8 on BE risk thus warrants further investigation.

The implications of hypersomnia in the context of major depression: Results from a large, international, observational study

“…In fact, obese patients show a higher risk of developing major MDD and BD ( Simon et al, 2006 ), but the course of bipolar depression is also frequently affected by the development of overweigh and obesity, possibly related to the effects of psychotropic medications or to comorbid diagnoses with eating disorders, such as binge eating disorder (BED). Notwithstanding, this association underpins genetic and neurobiological liability ( McElroy et al, 2018( McElroy et al, , 2013( McElroy et al, , 2011McElroy and Keck, 2014 ). In BD, obesity is directly associated with a worse illness course and outcome, including increased suicidality and decreased cognitive performance ( Fagiolini et al, 2004;Yim et al, 2012 ).…”

Mood‐Stabilizing Antiepileptic Treatment Response in Bipolar Disorder: A Genome‐Wide Association Study

“…13 Genotyping, quality control, and imputation procedures have been described elsewhere. 13 After quality control and imputation, a total of 7,368,687 SNPs were included in the GWAS analysis. GWAS analyses were performed in PLINK v1.90b3v, 14 with additional regression analyses performed using R-3.2.3.…”

The Emerging Landscape of Epidemiological Research Based on Biobanks Linked to Electronic Health Records: Existing Resources, Analytic Challenges and Potential Opportunities

“…Common psychiatric and neurologic outcomes include risk-taking behavior, 78,79 depression/major depressive disorder, 78,80,89,[81][82][83][84][85][86][87][88] Alzheimer's disease, 22,81,87,88,90 anxiety, 78,79,82 schizophrenia, 78,82,83,87,88 and bipolar disorder. 78,82,83,87,88,[91][92][93] These outcomes are ascertained by either diagnosis codes or survey responses, and different definitions and thresholds are used in sensitivity analyses. Similarly, cardiovascular disease outcomes include coronary artery disease/coronary heart disease, 32,54,[98][99][100]55,64,87,88,[94][95][96][97] which are defined as a combination of more specific conditions including myocardial infarction.…”